Exponent, Inc. (EXPO) SEC Filings & Earnings Calls
EquiReason read 10 Exponent, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — Exponent reported Q2 2026 revenue up 21% YoY to $171.6M, net income up 11% to $29.4M, driven by AI-related user research and strong utilization..
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
- Market cap
- 3.7B
- P/E TTM
- 34.7
- Dividend yield
- 1.6%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
7 Aug 202610-QExponent reported Q2 2026 revenue up 21% YoY to $171.6M, net income up 11% to $29.4M, driven by AI-related user research and strong utilization.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q2-2026 | $172M | +21% y/y |
| Net income · Q2-2026 | $29M | +11% y/y |
| Diluted EPS · Q2-2026 | $0.60 | +15% y/y |
| Billable hours · Q2-2026 | 390,000 | +9% y/y |
| Utilization · Q2-2026 | 74.0% | |
| Average technical FTE employees · Q2-2026 | 1,012 | +6% y/y |
| EBITDA · Q2-2026 | $43M | +16% y/y |
Risks flagged
Concentration risk from large project
“This work includes a large study that represented approximately 4% of our net revenues during the quarter.” · word for word
Dependence on AI-related demand sustainability
“Our proactive work experienced strong growth in the quarter, led by demand for user research studies as clients accelerate the development of AI-enabled products.” · word for word
30 Jul 20268-K · 2.02, 7.01Exponent reported Q2 2026 revenue growth of 21% to $171.6M, net income up to $29.4M from $26.6M, and raised FY2026 guidance for revenue growth to 9%-10% and EBITDA margin to 27.8%-28.1%. Also declared $0.31 dividend and authorized $50M buybearningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q2-2026 | $172M | +21% y/y |
| Revenues before reimbursements · Q2-2026 | $149M | +12% y/y |
| Net income · Q2-2026 | $29M | +11% y/y |
| Earnings per share, diluted · Q2-2026 | $0.60 | +15% y/y |
| EBITDA · Q2-2026 | $43M | +15% y/y |
| EBITDA margin · Q2-2026 | 28.7% | |
| Consolidated tax rate · Q2-2026 | 27.9% | |
| Utilization · Q2-2026 | 74.0% | |
| Cash and cash equivalents · Q2-2026 | $67M | |
| Dividends paid · H1-2026 | $31M |
Guidance
FY2026 revenues before reimbursements growth raised to 9%-10% from prior; FY2026 EBITDA margin raised to 27.8%-28.1% from prior; Q3 revenues before reimbursements growth 8%-10%; Q3 EBITDA margin 28.0%-28.5%
Raised FY2026 guidance for revenue growth and EBITDA margin, reflecting strong demand and disciplined execution.
Risks flagged
No specific new risks identified; standard forward-looking statements.
“Factors that could cause material differences include demand decline, timing of engagements, competitive services, absence of backlog, ability to retain key employees, tort reform, and government regulation.”
8 May 202610-QRevenue $166M (+14% y/y); Net Income $30M (+11% y/y); Billable Hours 399,000 (+6% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $166M | +14% y/y |
| Net Income · Q1-2026 | $30M | +11% y/y |
| Billable Hours · Q1-2026 | 399,000 | +6% y/y |
| Utilization · Q1-2026 | 76.0% | |
| Technical FTE Employees · Q1-2026 | 1,013 | +5% y/y |
| EBITDA · Q1-2026 | $43M | +15% y/y |
| EBITDA Margin · Q1-2026 | 28.4% | |
| Engineering & Other Scientific Revenue · Engineering and Other Scientific · Q1-2026 | $141M | +16% y/y |
| Environmental & Health Revenue · Environmental and Health · Q1-2026 | $25M | +7% y/y |
| Diluted EPS · Q1-2026 | $0.59 | +14% y/y |
Risks flagged
Deferred compensation volatility
“The increase in corporate operating expenses was due to the change in value of assets associated with our deferred compensation plan.” · word for word
Interest income decline
“During the first quarter of 2026 interest income decreased by $996,000 due to a decrease in interest rates and lower average cash equivalent balances.” · word for word
30 Apr 20268-K · 2.02, 7.01Total revenues $166M (+14% y/y); Net income $30M (+11% y/y); EBITDA $43M (+15% y/y); Guidance: High-single-digit revenue growth for FY2026earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q1-2026 | $166M | +14% y/y |
| Net income · Q1-2026 | $30M | +11% y/y |
| EBITDA · Q1-2026 | $43M | +15% y/y |
| Diluted EPS · Q1-2026 | $0.59 | +14% y/y |
| Utilization · Q1-2026 | 76.0% |
Guidance
High-single-digit revenue growth for FY2026
Guidance reaffirmed: high-single-digit revenue growth, EBITDA margin 27.6%-28.1% for FY2026
20 Apr 2026DEF 14AProxy statement filed for shareholder vote; no material event.open
Figures in the filing · each found in the filing text
| Net income · FY2025 | $106M | |
| EBITDA · FY2025 | $148M | |
| Total Shareholder Return · FY2025 | $82.00 | |
| Employee bonus pool · FY2025 | $77M |
6 Apr 20268-K · 5.02President base salary $650,000.00; CFO base salary $525,000.00; President stock options 21,000open
Figures in the filing · each found in the filing text
| President base salary | $650000.00 | |
| CFO base salary | $525000.00 | |
| President stock options | 21,000 | |
| CFO stock options | 12,600 |
Risks flagged
Leadership transition risk; new President and CFO taking over, though both are internal promotions.
“Appointment of new President and CFO effective May 1, 2026. Both are internal candidates with long tenure.”
Board retirement of Chairman may reduce institutional knowledge.
“Paul R. Johnston retiring from Board effective June 4, 2026. Karen Richardson to become Chairman.”
27 Feb 202610-KTechnical full-time equivalent employees 973 (+1% y/y); Total employees 1,212; Employees with advanced degrees 922open
Figures in the filing · each found in the filing text
| Technical full-time equivalent employees · FY2025 | 973 | +1% y/y |
| Total employees · 2026-01-02 | 1,212 | |
| Employees with advanced degrees · 2026-01-02 | 922 | |
| Employees with doctorate degrees · 2026-01-02 | 731 | |
| Revenue concentration - consumer products · FY2025 | 21.0% | |
| Revenue concentration - energy and utilities · FY2025 | 20.0% | |
| Revenue concentration - transportation · FY2025 | 16.0% | |
| Revenue concentration - chemical · FY2025 | 11.0% | |
| Standard billing rate - low · FY2025 | $225.00 | |
| Standard billing rate - high · FY2025 | $1375.00 |
Risks flagged
Competitive Pricing Pressure
“Although we believe that we generally compete favorably in each of these areas, some of our competitors may be able to provide services acceptable to our clients at lower prices.” · word for word
Low Barriers to Entry
“We believe that the barriers to entry are low and that for many of our technical disciplines, competition is increasing.” · word for word
Dependence on Key Personnel
“Our success depends, to a significant degree, on our ability to attract and retain highly-skilled and qualified personnel, as well as the continued contributions of those individuals.”
Litigation and Liability Risk
“We face risks of loss resulting from, but not limited to, errors relating to transaction processing and technology, breaches of our internal control system or external compliance requirements, fraud or unauthorized transactions by employees or third parties, cybersecurity incidents, ineffective business continuation and disaster recovery activities.”
5 Feb 20268-K · 2.02, 7.01Total revenues $147M (+8% y/y); Revenues before reimbursements $129M (+4% y/y); Net income $25M (+5% y/y); Guidance: FY2026 revenue growth high-single digits; EBITDA margin 27.6%-28.1%earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q4-2025 | $147M | +8% y/y |
| Revenues before reimbursements · Q4-2025 | $129M | +5% y/y |
| Net income · Q4-2025 | $25M | +5% y/y |
| EBITDA · Q4-2025 | $35M | +11% y/y |
| EBITDA margin · Q4-2025 | 26.8% | |
| Total revenues · FY2025 | $582M | +4% y/y |
| Net income · FY2025 | $106M | -3% y/y |
| EBITDA · FY2025 | $148M | +1% y/y |
| EPS diluted · Q4-2025 | $0.49 | +7% y/y |
| EPS diluted · FY2025 | $2.07 | -2% y/y |
Guidance
FY2026 revenue growth high-single digits; EBITDA margin 27.6%-28.1%
Guidance for high-single digit revenue growth in FY2026; EBITDA margin expected to expand to 27.6%-28.1%.
7 Nov 202510-QExponent reported Q3 2025 results with 8% revenue growth, 8% net income growth, and announced a new $100M buyback authorization.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $147M | +8% y/y |
| Net income · Q3-2025 | $28M | +8% y/y |
| Diluted EPS · Q3-2025 | $0.55 | +10% y/y |
| EBITDA · Q3-2025 | $39M | +9% y/y |
| Utilization · Q3-2025 | 74.0% | |
| Technical full-time equivalent employees · Q3-2025 | 976 | +3% y/y |
| Engineering & Other Scientific Revenue · Engineering & Other Scientific · Q3-2025 | $124M | +8% y/y |
| Environmental & Health Revenue · Environmental & Health · Q3-2025 | $23M | +10% y/y |
| Operating Cash Flow · 9M-2025 | $76M | -14% y/y |
| Free Cash Flow · 9M-2025 | $69M | -18% y/y |
Risks flagged
Dependence on key employees and talent retention
“We expect our compensation expense, excluding the change in value of deferred compensation plan assets, to increase as we selectively add new talent and adjust compensation to market conditions.” · word for word
Lease obligation risk
“On June 19, 2024, we entered into an agreement with the State of Arizona to extend our land lease for 15 years beginning on January 17, 2028... Beginning on January 17, 2028, our payments under the lease will increase to approximately $6,183,000 per year for the 15-year extension term.” · word for word
30 Oct 20258-K · 2.02, 7.01Total revenues $147M (+8% y/y); Revenues before reimbursements $137M (+10% y/y); Net income $28M (+8% y/y); Guidance: Raising margin guidanceearningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q3-2025 | $147M | +8% y/y |
| Revenues before reimbursements · Q3-2025 | $137M | +10% y/y |
| Net income · Q3-2025 | $28M | +8% y/y |
| EPS diluted · Q3-2025 | $0.55 | +10% y/y |
| EBITDA · Q3-2025 | $39M | +8% y/y |
| EBITDA margin · Q3-2025 | 28.3% | |
| Cash and cash equivalents · Q3-2025 | $207M |
Guidance
Raising margin guidance
Maintaining revenue guidance, raising margin guidance for full year 2025.
Risks flagged
Q4 2025 faces a 14th-week headwind vs prior year.
“Exponent is returning to a 13-week fiscal fourth quarter in 2025, which poses a headwind for comparisons since Q4 of fiscal 2024 benefited from a 14th week.” · word for word
Exponent, Inc. — questions
- What did Exponent, Inc. file recently?
- 10 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — Exponent reported Q2 2026 revenue up 21% YoY to $171.6M, net income up 11% to $29.4M, driven by AI-related user research and strong utilization.
Every figure on this page comes from Exponent, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.